Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein

被引:41
作者
Armes, Jane E.
Lourie, Rohan
de Silva, Melanie
Stamaratis, Georgia
Boyd, Alison
Kumar, Beena
Price, Gareth
Hyde, Simon
Allen, David
Grant, Peter
Venter, Deon J.
机构
[1] St Vincents Hosp, Dept Pathol Anat, Fitzroy, Vic 3065, Australia
[2] Victorian Breast Canc Res Consortium, Mol Pathol Lab, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia
[4] Royal Childrens Hosp, Murdoch Childrens Res Inst, Canc Genom Lab, Melbourne, Vic, Australia
[5] Mercy Hosp Women, Dept Gynaecol Oncol, Melbourne, Australia
[6] Womens & Childrens Hlth, Dept Pathol, Melbourne, Vic, Australia
关键词
ovarian cancer; p16-RB1; pathway; tissue microarrays immunohistochemistry;
D O I
10.1097/01.pgp.0000172083.94934.1e
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Dysfunction of proteins involved in the G1 to S transition of the cell cycle, such as p16(INK4A) and RB1, is common in many cancer types. A screen of p16 protein expression was performed in benign, borderline, and invasive ovarian tumors, together with endometrial cancers, aligned on a tissue microarray. We observed frequent p 16 overexpression in serous papillary carcinomas of ovarian and endometrial origin. An extended cohort of ovarian serous papillary carcinomas was examined to further evaluate the frequency of p16 overexpression. Strong, uniform staining in the majority of cancer cells occurred commonly in invasive serous papillary ovarian cancers, particularly in grade 3 carcinomas. RB1 protein expression abnormalities were rare. Our data indicate that abnormalities in the retinoblastoma pathway, as determined by p16 overexpression, are common in serous papillary carcinomas and are probably an early event.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 25 条
[1]  
Armes JE, 1999, CANCER RES, V59, P2011
[2]   LOH AND MUTATION ANALYSIS OF CDKN2 IN PRIMARY HUMAN OVARIAN CANCERS [J].
CAMPBELL, IG ;
BEYNON, G ;
DAVIS, M ;
ENGLEFIELD, P .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) :222-225
[3]  
Dong Y, 1997, INT J CANCER, V74, P407, DOI 10.1002/(SICI)1097-0215(19970822)74:4<407::AID-IJC8>3.3.CO
[4]  
2-G
[5]   DELETIONS OF A DNA-SEQUENCE IN RETINOBLASTOMAS AND MESENCHYMAL TUMORS - ORGANIZATION OF THE SEQUENCE AND ITS ENCODED PROTEIN [J].
FRIEND, SH ;
HOROWITZ, JM ;
GERBER, MR ;
WANG, XF ;
BOGENMANN, E ;
LI, FP ;
WEINBERG, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9059-9063
[6]  
Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61
[7]   Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular Pathologic data [J].
Gilks, CB .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (03) :200-205
[8]   Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: A molecular, immunohistochemical, and clinicopathologic study [J].
Gras, E ;
Pons, C ;
Machin, P ;
Matias-Guiu, X ;
Prat, J .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2001, 20 (04) :335-340
[9]  
Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396
[10]  
KNUDSON AG, 1978, SEMIN ONCOL, V5, P57